Global Med Form 12b-25--Form 10-Q
      Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

                                              UNITED STATES                            OMB APPROVAL
                                    SECURITIES AND EXCHANGE COMMISSION         -----------------------------
                                         Washington, D.C. 20549                OMB Number:         3235-0058
                                                                               Expires:    January 31, 2005
                                                                               Estimated average burden
                                               FORM 12b-25                      hours per response ..... 2.50
                                      NOTIFICATION OF LATE FILING                      SEC FILE NUMBER
(Check One):                                                                   -----------------------------
 [ ] Form 10-K  [ ]  Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR               CUSIP NUMBER
     For Period Ended: March 31, 2003                                             -----------------------------

     [ ] Transition Report on Form 10-K
     [ ] Transition Report on Form 20-F
     [ ] Transition Report on Form 11-K
     [ ] Transition Report on Form 10-Q
     [ ] Transition Report on Form N-SAR
     For the Transition Period Ended: __________________________________________

    Read attached instruction sheet before preparing form. Please print or type.

    Nothing in this form shall be  construed to imply that the  Commission  has
verified any information contained herein.

    If the  notification  relates  to a portion of the  filing  checked  above,
identify the item(s) to which the notification relates: ________________________


Full Name of Registrant
Former Name if Applicable

12600 West Colfax, Suite C-420
Address of Principal Executive Office (Street and Number)

Lakewood, Colorado 80215
City, State and Zip Code

PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate.)

     |    (a)  The reasons  described in  reasonable  detail in Part III of this
     |         form  could  not be  eliminated  without  unreasonable  effort or
     |         expense;
[X]  |    (b)  The subject annual report,  semi-annual report, transition report
     |         on Form 10-K,  20-F,  11-K or Form N-SAR, or portion thereof will
     |         be filed  on or  before  the  15th  calendar  day  following  the
     |         prescribed  due  date;  or  the  subject   quarterly   report  or
     |         transition  report on Form 10-Q, or portion thereof will be filed
     |         on or before the fifth  calendar day following the prescribed due
     |         date; and
     |    (c)  The  accountant's  statement  or other  exhibit  required by Rule
     |         12b-25(c) has been attached if applicable.


State below in reasonable  detail the reasons why Forms 10-K,  20-F, 11-K, 10-Q,
N-SAR, or the transition  report or portion  thereof,  could not be filed within
the prescribed time period.

          Registrant has encountered  delays in completing its Quarterly  Report
     on Form 10-Q for the quarter  ended March 31, 2003,  because  management of
     the Company is still finalizing the financial statements as well as certain
     disclosures that are not financial in nature.


(1) Name and telephone number of person to contact in regard to this notification

     Michael I. Ruxin, M.D        (303)                    238-2000
        (Name)                 (Area Code)             (Telephone Number)

(2)  Have all other periodic  reports  required under Section 13 or 15(d) of the
     Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
     of 1940 during the preceding 12 months or for such shorter  period that the
     registrant was required to file such report(s) been filed? If the answer is
     no, identify report(s).
                                                                 [X] Yes  [ ] No

(3)  Is it anticipated that any significant change in results of operations from
     the corresponding  period for the last fiscal year will be reflected by the
     earnings  statements  to be  included  in the  subject  report  or  portion
                                                                 [X] Yes  [ ] No

     If so: attach an explanation of the anticipated  change,  both  narratively
     and quantitatively, and, if appropriate, state the reasons why a reasonable
     estimate of the results cannot be made.

               Registrant has encountered delays in completing its Form 10-Q for
          the three months ended March 31, 2003,  because the  Registrant  is in
          the  process  of  finalizing  the  financial  statements  and  certain
          non-financial disclosures.


                          GLOBAL MED TECHNOLOGIES, INC.
                  (Name of Registrant as Specified in Charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
hereunto duly authorized.

Date: May 16, 2003                        By /s/ Michael I. Ruxin
                                             Michael I. Ruxin, M.D.
                                             Chairman of the Board and
                                             Chief Executive Office

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.


Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (see 18 U.S.C. 1001).